Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.9K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.5K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

368
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
368
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Anti-phasic oscillatory development for speech and noise processing in cochlear implanted toddlers.

Child development·2024
Same author

Data-balanced transformer for accelerated ionizable lipid nanoparticles screening in mRNA delivery.

Briefings in bioinformatics·2024
Same author

Nitrogen and sulfur cycling and their coupling mechanisms in eutrophic lake sediment microbiomes.

The Science of the total environment·2024
Same author

Histopathology language-image representation learning for fine-grained digital pathology cross-modal retrieval.

Medical image analysis·2024
Same author

FOXO3/Rab7-Mediated Lipophagy and Its Role in Zn-Induced Lipid Metabolism in Yellow Catfish (<i>Pelteobagrus fulvidraco</i>).

Genes·2024
Same author

A One-Pot Convenient RPA-CRISPR-Based Assay for <i>Salmonella enterica</i> Serovar Indiana Detection.

Microorganisms·2024

相关实验视频

Updated: Jun 29, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K

MFSynDCP:多源功能协作互动学习,用于药物组合协同预测.

Yunyun Dong1, Yunqing Chang2, Yuxiang Wang2

  • 1School of Software, Taiyuan University of Technology, Taiyuan, Shanxi, China. dongyunyun@tyut.edu.cn.

BMC bioinformatics
|April 2, 2024
PubMed
概括

预测用于癌症治疗的协同药物组合是至关重要的. 一个新的模型,MFSynDCP,使用多源特征交互学习来准确识别有效的抗瘤药物组合,优于现有方法.

关键词:
这是一种抗瘤药物.深度学习是一种深度学习.药物组合 药物组合是一种药物组合.图表注意力网络 图表注意力网络有协同效应的效应.

更多相关视频

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

相关实验视频

Last Updated: Jun 29, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

科学领域:

  • 在瘤学瘤学.
  • 计算生物学 计算生物学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 药物组合疗法在癌症治疗中提供了比单一疗法更高的疗效.
  • 鉴定协同药物组合是非常重要的,因为许多药物类别和潜在的相互作用.
  • 当前的预测方法往往忽略了关键的细胞系与药物相互作用机制.

研究的目的:

  • 开发一种用于预测抗瘤药物组合协同作用的新型计算模型.
  • 通过结合多源功能交互学习来解决现有方法的局限性.
  • 提高对药物组合中的协同效应的全面理解.

主要方法:

  • 拟议的MFSynDCP (药物组合的多源特征协同预测) 模型.
  • 利用带有适应性注意力机制的图形聚合模块来学习药物相互作用.
  • 实现了一个多源功能交互学习控制器,用于整合药物和细胞系数据.

主要成果:

  • 与对基准数据集的现有方法相比,MFSynDCP表现优越.
  • 适应性注意力机制确定了促进协同作用的关键药物化学子结构.
  • 该模型有效地整合了多样化的数据源,以实现强大的协同效应预测.

结论:

  • MFSynDCP是一种强大而稳健的工具,用于预测协同作用的抗瘤药物组合.
  • 该模型增强了对组合治疗中药物相互作用机制的理解.
  • 这种方法有助于发现更有效的癌症治疗策略.